» Articles » PMID: 12097271

Inactivation of LKB1/STK11 is a Common Event in Adenocarcinomas of the Lung

Overview
Journal Cancer Res
Specialty Oncology
Date 2002 Jul 5
PMID 12097271
Citations 301
Authors
Affiliations
Soon will be listed here.
Abstract

Frequent losses of chromosome 19p have recently been observed in sporadic lung adenocarcinomas, targeting the location of a critical tumor suppressor gene. Here we performed fine mapping of the short arm of chromosome 19 and found that the LKB1/STK11 gene mapped in the minimal-deleted region. Because germ-line mutations at LKB1/STK11 result in the Peutz-Jeghers syndrome and an increased risk of cancer, we performed a detailed genetic screen of the LKB1/STK11 gene in lung tumors. We detected a high frequency of somatic alterations (mainly nonsense mutations) in primary lung adenocarcinomas and in lung cancer cell lines. Thus, our findings demonstrate for the first time that LKB1/STK11 inactivation is a very common event and may be integrally involved in the development of sporadic lung adenocarcinoma.

Citing Articles

A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer.

Middleton G, Robbins H, Fletcher P, Savage J, Mehmi M, Summers Y NPJ Precis Oncol. 2025; 9(1):67.

PMID: 40069402 PMC: 11897347. DOI: 10.1038/s41698-025-00838-4.


Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection.

Sugawara T, Hakozaki T, Seike M, Hosomi Y Transl Cancer Res. 2025; 14(1):29-32.

PMID: 39974381 PMC: 11833390. DOI: 10.21037/tcr-24-1734.


Alu-Sc-mediated exonization generated a mitochondrial LKB1 gene variant found only in higher order primates.

Tan I, Chothani S, Lim H, Lam K Sci Rep. 2025; 15(1):3360.

PMID: 39870744 PMC: 11772596. DOI: 10.1038/s41598-025-86789-z.


Insights into targeting LKB1 in tumorigenesis.

Trelford C, Shepherd T Genes Dis. 2024; 12(2):101402.

PMID: 39735555 PMC: 11681833. DOI: 10.1016/j.gendis.2024.101402.


Inhibition of ULK1/2 and KRAS controls tumor growth in preclinical models of lung cancer.

Ghazi P, OToole K, Srinivas Boggaram S, Scherzer M, Silvis M, Zhang Y Elife. 2024; 13.

PMID: 39213022 PMC: 11364435. DOI: 10.7554/eLife.96992.